ReviewCureus2025
Venous Thromboembolism in Dermatological, Pulmonary, and Cardiac Disorders: A Systematic Review of Emergency Presentations and Interdisciplinary Management Strategies.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant clinical challenge due to its multifaceted presentation and high morbidity and mortality. While commonly linked with surgical and oncological settings, VTE also emerges in association with dermatological, pulmonary, and cardiac disorders, often complicating their clinical course and management. This systematic review aims to elucidate the emergency presentations and interdisciplinary management strategies of VTE within dermatological, pulmonary, and cardiac conditions, emphasizing early detection and coordinated care. A comprehensive literature search was conducted across multiple databases, including PubMed, Scopus, and Web of Science, up to January 2025. Studies were screened and selected based on predefined inclusion criteria focusing on VTE occurrences in patients with dermatologic, pulmonary, or cardiac pathologies. Data on clinical presentation, diagnostic modalities, treatment strategies, and outcomes were extracted and synthesized. The review highlights diverse VTE manifestations across the three disciplines. Dermatological conditions, such as pyoderma gangrenosum and systemic vasculitides, exhibit prothrombotic states, while pulmonary disorders, notably chronic obstructive pulmonary disease (COPD) and interstitial lung disease, show increased VTE risk due to hypoxia and immobility. Cardiac conditions, including atrial fibrillation and heart failure, frequently precipitate thromboembolic events. Management involves a combination of anticoagulation, targeted therapy for underlying conditions, and collaborative care between dermatologists, pulmonologists, cardiologists, and emergency physicians. VTE in dermatological, pulmonary, and cardiac contexts necessitates heightened clinical awareness and interdisciplinary collaboration for optimal outcomes. Early recognition and tailored management strategies can significantly reduce VTE-associated complications, underscoring the need for integrated emergency protocols and continued research in these intersecting domains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.